Edward F Patz

Characterising phase variations in MALDI-TOF data and correcting them by peak alignment

Simon M Lin, Richard P Haney, Michael J Campa, 2005, Cancer informatics.

Estimate of lung cancer mortality from low-dose spiral computed tomography screening trials: implications for current mass screening recommendations.

Edward F Patz, S. Swensen, J. Herndon, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The role of imaging in malignant pleural mesothelioma.

Edward F Patz, Edith M Marom, H. Pass, 2002, Seminars in oncology.

A comparative analysis of EGFR-targeting antibodies for gold nanoparticle CT imaging of lung cancer

Cristian T Badea, Jeffrey R. Ashton, Edward F Patz, 2018, PloS one.

Development of novel tumor imaging agents with phage-display combinatorial peptide libraries.

Michael J Campa, Edward F Patz, M. Campa, 2002, Academic radiology.

Protein expression profiling identifies macrophage migration inhibitory factor and cyclophilin a as potential molecular targets in non-small cell lung cancer.

Michael J Campa, Michael C Fitzgerald, Edward F Patz, 2003, Cancer research.

Stage migration, selection bias, and survival associated with the adoption of positron emission tomography among medicare beneficiaries with non-small-cell lung cancer, 1998-2003.

Amy P Abernethy, Lesley H Curtis, Morris Weinberger, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Identification and validation of a potential lung cancer serum biomarker detected by matrix‐assisted laser desorption/ionization‐time of flight spectra analysis

Michael J Campa, Michael C Fitzgerald, Edward F Patz, 2003, Proteomics.

Panel of serum biomarkers for the diagnosis of lung cancer.

Irina Kusmartseva, Michael J Campa, Edward F Patz, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.